Executive Assistant
Maryland Oncology HematologyHighlight
Summary
About the Role
About You
- High School diploma or equivalent; Associate's degree in business administration or office administration program required.
- Minimum of five years of experience providing administrative support to senior-level executives in a fast-paced environment.
- Strong interpersonal capabilities and excellent communication skills.
- Project management experience.
- Bachelor’s Degree.
- Experience in a clinical environment.
- Strong knowledge of Microsoft Office products, especially Excel, Word, and PowerPoint.
Benefits
- Competitive annual salary ranging from $80k to $121k depending on skills and experience.
- Opportunity to work in a dynamic healthcare environment.
Maryland Oncology Hematology was founded in 1986 by Dr. Jon Minford and was the first to provide medical oncology and hematology care to residents in the growing Howard county area of Maryland. Over the years MOH has continued to grow to become the largest community-based Oncology/Hematology practice in the state of Maryland. Currently, MOH has 13 locations and 400+ employees. Our practice locations include Columbia, Lanham, Clinton, Brandywine, Silver Spring, Laurel, Rockville, Bethesda, Germantown, Frederick, Mt. Airy, and Annapolis. Our services have also expanded beyond Oncology to include Radiation Oncology, Genetics, Clinical Research, Behavioral Health, and various surgical specialties. We currently have over 60 Physicians and Advance Practice Professionals to provide care to over 50,000 patients. Maryland Oncology Hematology is united in healing with The US Oncology Network, one of the nation’s largest community-based cancer treatment and research networks focused on advancing cancer care in America. As an affiliate of The US Oncology Network, Maryland Oncology Hematology is united with approximately 1,600 physicians and 10,000 cancer professionals nationwide. Maryland Oncology Hematology participates in clinical trials through US Oncology Research, which has helped to develop FDA approved cancer therapies.